Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Privia Health (PRVA) EBIT (2020 - 2025)

Privia Health (PRVA) has 6 years of EBIT data on record, last reported at $11.3 million in Q4 2025.

  • For Q4 2025, EBIT rose 114.9% year-over-year to $11.3 million; the TTM value through Dec 2025 reached $34.2 million, up 101.6%, while the annual FY2025 figure was $34.2 million, 101.6% up from the prior year.
  • EBIT reached $11.3 million in Q4 2025 per PRVA's latest filing, down from $14.4 million in the prior quarter.
  • Across five years, EBIT topped out at $14.4 million in Q3 2025 and bottomed at -$193.2 million in Q2 2021.
  • Average EBIT over 5 years is -$8.2 million, with a median of $4.2 million recorded in 2024.
  • Peak YoY movement for EBIT: crashed 3226.51% in 2021, then skyrocketed 534.02% in 2025.
  • A 5-year view of EBIT shows it stood at -$19.3 million in 2021, then surged by 111.62% to $2.2 million in 2022, then tumbled by 36.86% to $1.4 million in 2023, then surged by 269.58% to $5.2 million in 2024, then skyrocketed by 114.9% to $11.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were $11.3 million in Q4 2025, $14.4 million in Q3 2025, and $3.3 million in Q2 2025.